Considered by some to be among the simpler forms of life, viruses represent
highly evolved natural vectors for the transfer of foreign genetic informa
tion into cells. This attribute has led to extensive attempts to engineer r
ecombinant viral vectors for the delivery of therapeutic genes into disease
d tissues. While substantial progress has been made, and some clinical succ
esses are over the horizon, further vector refinement and/or development is
required before gene therapy will become standard care for any individual
disorder.